JPMorgan Upgrades Diebold (DBD) to Overweight
Tweet Send to a Friend
JPMorgan upgraded Diebold (NYSE: DBD) from Neutral to Overweight with a price target of $24.00 (from $29.00).Analyst Paul ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


